semaglutide in chronic kidney disease Long-term outcomes of obesity and cardiovascular in the SELECT trial can semaglutide cause kidney problems

This may be due to its role in downregulating naive genes (Fig

A 2019 meta-analysis noted mixed outcomes in autoimmune thyroid conditions, with some studies showing reduced TPO antibodies and improved TSH control, while others showed minimal clinical benefit

Key Takeaway: The best way to handle a missed dose is to stay calm, check the timeline, and prioritize safety over catching up. To see if a personalized, medically supervised weight loss program is right for you, complete our free assessment quiz

Only 1.6% of participants discontinued due to nausea, meaning the vast majority found it manageable over time (Wilding et al., NEJM 2021)